rss

See original article: 70 (8): 1519.

See original article: Barkham et al. 69 (11): 1926.

See original article: Jamnitski et al. 69 (11): 1929.

See original article: Saleem et al. 69 (9): 1636.

See original article: Eyre et al. 69 (8): 1572.

See original article: Eyre et al. 69 (7): 1407.

See original article: Haugeberg et al. 69 (7): 1364.

See original article: Cohen et al. 69 (6): 1158.

See original article: Dixon et al. 69 (6): 1086.

See original article: Smolen et al. 69 (6): 964.

See original article: Nam et al. 69 (6): 976.

See original article: Tan et al. 69 (6): 1029.

See original article: Robinson et al. 69 (6): 1054.

See original article: Bennett et al. 69 (5): 891.

See original article: Orozco et al. 69 (5): 813.

See original article: Burr et al. 69 (4): 666.

See original article: Schoels et al. 69 (4): 638.

See original article: Smolen et al. 69 (4): 631.

See original article: Emery et al. 69 (3): 510.

See original article: Schoels et al. 69 (3): 575.

See original article: Machold et al. 69 (3): 495.

See original article: Freeston et al. 69 (2): 417.

See original article: Jones et al. 69 (2): 450.

See original article: Alten et al. 69 (2): 364.

See original article: Kekow et al. 69 (01): 222.

See original article: Furst et al. 69 (Suppl 1): i2.

See original article: Genovese et al. 68 (12): 1894.

See original article: Haugeberg et al. 68 (12): 1898.

See original article: Marzo-Ortega et al. 68 (11): 1721.

See original article: Gilworth et al. 68 (11): 1686.

See original article: Jarrett et al. 68 (9): 1466.

See original article: Buch et al. 68 (7): 1220.

See original article: Smolen et al. 68 (6): 823.

See original article: Rudwaleit et al. 68 (6): 770.

See original article: Bennett et al. 68 (6): 765.

See original article: Bejarano et al. 68 (5): 761.

See original article: Emery et al. 68 (4): 456.

See original article: Keystone et al. 68 (2): 216.

See original article: Doward et al. 68 (2): 196.

See original article: Potter et al. 68 (1): 69.

Correction to Keystone et al. 68 (2): 216
Correction to Doward et al. 68 (2): 196
Correction to Potter et al. 68 (1): 69
Correction to Smolen et al. 68 (6): 823
Correction to Buch et al. 68 (7): 1220
Correction to Emery et al. 68 (4): 456
Correction to Bejarano et al. 68 (5): 761
Correction to Rudwaleit et al. 68 (6): 770
Correction to Bennett et al. 68 (6): 765
Correction to Marzo-Ortega et al. 68 (11): 1721
Correction to Gilworth et al. 68 (11): 1686
Correction to Jarrett et al. 68 (9): 1466
Correction to Haugeberg et al. 68 (12): 1898
Correction to Genovese et al. 68 (12): 1894
Correction to Kekow et al. 69 (01): 222
Correction to Furst et al. 69 (Suppl 1): i2
Correction to Freeston et al. 69 (2): 417
Correction to Jones et al. 69 (2): 450
Correction to Alten et al. 69 (2): 364
Correction to Machold et al. 69 (3): 495
Correction to Schoels et al. 69 (4): 638
Correction to Smolen et al. 69 (4): 631
Correction to Burr et al. 69 (4): 666
Correction to Emery et al. 69 (3): 510
Correction to Bennett et al. 69 (5): 891
Correction to Nam et al. 69 (6): 976
Correction to Smolen et al. 69 (6): 964
Correction to Tan et al. 69 (6): 1029
Correction to Robinson et al. 69 (6): 1054
Correction to Cohen et al. 69 (6): 1158
Correction to Haugeberg et al. 69 (7): 1364
Correction to Schoels et al. 69 (3): 575
Correction to Eyre et al. 69 (7): 1407
Correction to Eyre et al. 69 (8): 1572
Correction to Orozco et al. 69 (5): 813
Correction to Saleem et al. 69 (9): 1636
Correction to Barkham et al. 69 (11): 1926
Correction to Jamnitski et al. 69 (11): 1929
Correction to Dixon et al. 69 (6): 1086
Ann Rheum Dis 70:1519 doi:10.1136/annrheumdis-2011-70-08
  • Miscellaneous
  • Corrections

Corrections

The department of one of the authors who co-authored all of the below papers has found that the affi liations were not correct. The correct affiliations for Professor P Emery, for all of the below articles, are: 1Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds; 2NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals Trust, Leeds, UK.

1. Keystone E, Emery P, Peterfy CG, et al. Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. Ann Rheum Dis 2009;68:216–21.

2. Doward LC, McKenna SP, Whalley D, et al. The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis 2009;68:196–200.

3. Potter C, Hyrich KL, Tracey A, et al. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-TNF response in RA. Ann Rheum Dis 2009;68:69–74.

4. Smolen JS, Han C, van der Heijde DM, et al.; Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group. Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. Ann Rheum Dis 2009;68:823–7.

5. Buch MH, Boyle DL, Rosengren S, et al. Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study. Ann Rheum Dis 2009;68:1220–7.

6. Emery P, Van Vollenhoven R, Ostergaard M, et al. Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe. …

Free sample This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of ARD.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article